Zobrazeno 1 - 10
of 30
pro vyhledávání: '"X. Fernández-Sala"'
Autor:
J. Barceló-Vidal, D. Echeverría-Esnal, N. Carballo, M. De Antonio-Cuscó, X. Fernández-Sala, M. E. Navarrete-Rouco, E. Colominas-González, S. Luque, M. Fuster-Esteva, L. Domingo, M. Sala, X. Duran, S. Grau, O. Ferrández
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Introduction: Drug-related problems (DRP) are events or circumstances in which drug therapy does or could interfere with desired health outcomes. In December 2019, a new coronavirus, SARS-CoV-2, appeared. Little knowledge about this type of infection
Externí odkaz:
https://doaj.org/article/d8c28ac897c1429aa94415c9d16ffb26
Autor:
J Barceló-Vidal, X Fernández-Sala, N Carballo, J Flores Le-Roux, A Aldea-Perona, P Díaz-Pellicer, J Miedes, O Ferrández, S Grau
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97c11f1d8a9c7c2a9780d6942a79381d
https://doi.org/10.1136/ejhpharm-2023-eahp.115
https://doi.org/10.1136/ejhpharm-2023-eahp.115
Autor:
L Río-No, E Colominas-Gonzalez, N Carballo, X Fernández-Sala, C Bosch, M Ferran, F Gallardo, S Grau, O Ferrández
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a74fc5b01d9b4253b890ff4ac28fa946
https://doi.org/10.1136/ejhpharm-2023-eahp.425
https://doi.org/10.1136/ejhpharm-2023-eahp.425
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41aec3db054135bad752b79090da8acd
https://doi.org/10.1136/ejhpharm-2023-eahp.416
https://doi.org/10.1136/ejhpharm-2023-eahp.416
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance The most frequent adverse effect of palbociclib is neutropenia, resulting in dose reductions and treatment interruptions. Recently, it has been reported that early palbociclib related neutropenia was associated with a prolon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::199bc4e6bb543ae7116f1688fd766408
https://doi.org/10.1136/ejhpharm-2021-eahpconf.123
https://doi.org/10.1136/ejhpharm-2021-eahpconf.123
Autor:
X Fernández-Sala, L. Comella-Anaya, Jaime Barceló-Vidal, E González-Colominas, C. López-Mula, Olivia Ferrández, P Acin, Sonia Luque, Daniel Echeverría-Esnal, N Carballo, M De Antonio-Cuscó
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Drug related problems (DRP) are common among hospitalised patients. During the COVID-19 pandemic, the number of inpatients increased and the pattern of drug use was varied which could lead to a higher number of potential DRP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0aada10311aa6ae7a06e527352222783
https://doi.org/10.1136/ejhpharm-2021-eahpconf.216
https://doi.org/10.1136/ejhpharm-2021-eahpconf.216
Autor:
Marta Riu, Santiago Grau, Olivia Ferrández, Xavier Duran-Jordan, X Fernández-Sala, Jaime Barceló-Vidal, E. Salas
Publikováno v:
Eur J Hosp Pharm
Objectives The growing number of drugs on the market makes it necessary to adapt hospital formularies in order to ensure consistent drug coverage. The aim of this study was to evaluate the impact of the prescription of non-formulary drugs (NFD) on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::452083e2af889aa2fc6406a123336d5c
https://europepmc.org/articles/PMC8640380/
https://europepmc.org/articles/PMC8640380/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Ferran, E González-Colominas, F Gallardo, X Fernández-Sala, Olivia Ferrández, E Beltrán, Santiago Grau, L Tarrasón, N Carballo, R Gonzalez, E Navarrete Rouco
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background A limited number of studies have evaluated medication adherence in psoriasis (PS) or psoriatic arthritis (PsA), reporting rates between 29% and 88% (medication possession ratio (MPR >80%)). However, until now no study has included apremila
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c808a4d3a24304a11a4bc0efde8b94ea
https://doi.org/10.1136/ejhpharm-2019-eahpconf.185
https://doi.org/10.1136/ejhpharm-2019-eahpconf.185